Wang J, Zhou C, Yao W, Wang Q, et al. Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2022 May 13. pii: S1470-2045(22)00224.
PMID: 35576956